The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study

Abstract Background Currently, the diagnosis and treatment of nasopharyngeal carcinoma (NPC) patients with residual cervical lymphadenopathy following radical radiotherapy with or without chemotherapy are challenging. We investigated the prognosis of NPC patients with residual cervical lymphadenopat...

Full description

Bibliographic Details
Main Authors: Sai-Lan Liu, Xue-Song Sun, Xiao-Yun Li, Lin-Quan Tang, Qiu-Yan Chen, Huan-Xin Lin, Yu-Jing Liang, Jin-Jie Yan, Chao Lin, Shan-Shan Guo, Li-Ting Liu, Yang Li, Hao-Jun Xie, Qing-Nan Tang, Hu Liang, Ling Guo, Hai-Qiang Mai
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Cancer Communications
Subjects:
Nasopharyngeal carcinoma
Residual cervical lymphadenopathy
Prognosis
Epstein-Barr virus
Fine needle aspiration cytology
Survival
Online Access:http://link.springer.com/article/10.1186/s40880-019-0357-9

Internet

http://link.springer.com/article/10.1186/s40880-019-0357-9

Similar Items